Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis
Date
2020Journal
Future Science OAPublisher
Future Medicine Ltd.Type
Article
Metadata
Show full item recordAbstract
Aim: To assess the ability of signature metabolites alone, or in combination with the model for end-stage liver disease-Na (MELD-Na) score to predict mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis. Materials & methods: Plasma metabolites were detected using ultrahigh-performance liquid chromatography/tandem mass spectrometry in 39 patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis. Mortality was predicted using Cox proportional hazards regression and time-dependent receiver operating characteristic curve analyses. Results: The top five metabolites with significantly greater accuracy than the MELD-Na score (area under the receiver operating characteristic curve [AUROC] = 0.7591) to predict 1-year mortality were myo-inositol (AUROC = 0.9537), N-Acetylputrescine (AUROC = 0.9018), trans-Aconitate (AUROC = 0.8880), erythronate (AUROC = 0.8345) and N6-carbamoylthreonyladenosine (AUROC = 0.8055). Several combined MELD-Na-metabolite models increased the accuracy of predicted 1-year mortality substantially (AUROC increased from 0.7591 up to 0.9392). Conclusion: Plasma metabolites have the potential to enhance the accuracy of mortality predictions, minimize underestimates of mortality in patients with cirrhosis and low MELD-Na scores, and promote equitable allocation of donor livers. Copyright 2020 The authors.Sponsors
National Institutes of Health, NIH P30DK056338, 17RDM005, P30DK084567; Agilent Technologies: 0300016016; Cancer Prevention and Research Institute of Texas, CPRIT: R01DK111522, RP170005, RP170295.Keyword
biomarkercirrhosis
liver transplantation
MELD-Na score
metabolite
metabolomics
mortality
myo-inositol
primary biliary cholangitis
primary sclerosing cholangitis
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079152538&doi=10.2144%2ffsoa-2019-0124&partnerID=40&md5=d04a775279b5f24dad9e89535cd4a51a; http://hdl.handle.net/10713/12029ae974a485f413a2113503eed53cd6c53
10.2144/fsoa-2019-0124